| |
Standard of Diagnosis
|
WHtR cut-off
|
|---|
|
Outcome
|
χ2
|
P
|
I2
|
χ2
|
P
|
I2
|
|---|
|
CMR3
|
NA
|
NA
|
NA
|
298.64
|
< 0.001
|
99 (99–100)
|
|
CMR2
|
NA
|
NA
|
NA
|
54.92
|
< 0.001
|
96 (94–99)
|
|
CMR1
|
NA
|
NA
|
NA
|
6.51
|
0.04
|
69 (31–100)
|
|
Elevated FBG
|
2.59
|
0.27
|
23 (0–100)
|
19.03
|
< 0.001
|
89 (79–100)
|
|
Elevated BP
|
1.46
|
0.48
|
0 (0–100)
|
169.46
|
< 0.001
|
99 (98–99)
|
|
Dyslipidaemia
|
NA
|
NA
|
NA
|
40.33
|
< 0.001
|
95 (91–99)
|
|
Elevated TG
|
2.84
|
0.24
|
30 (0–100)
|
6.7
|
0.04
|
70 (33–100)
|
|
Low HDL-C
|
3.05
|
0.22
|
35 (0–100)
|
9.89
|
0.01
|
80 (56–100)
|
|
Central obesity
|
1.77
|
0.47
|
0 (0–100)
|
1.34
|
0.51
|
0 (0–100)
|
- NA not applicable, WHtR waist-to-height ratio, CMR cardiometabolic risk factor, CMR3 presenting with at least three CMRs, CMR2 presenting with at least two CMRs, CMR1 presenting with least one of CMRs, FBG fasting blood glucose; BP blood pressure, TG triglyceride, HDL-C High-density leptin cholesterol; The results of elevated total cholesterol, high low-density leptin cholesterol, and SBP/DBP blood pressure were not reported
